close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about AstraZeneca PLC

Recent news which mentions AstraZeneca PLC

< Previous 1 2 3 4 5 Next >
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Microsoft Corp Amazon/com Inc Science
From CNBC.com News
CNBC's Inside India newsletter: A slowing economy hasn't dimmed India's allure at Davos
Tags Inside India World News PepsiCo Inc/
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Novo Nordisk A/S Breaking News: Business US: News
From CNBC.com News
J&J says its lung cancer drug combination keeps people alive longer
Tags Health care industry Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Health care industry Pfizer Inc Health & Science
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Biotech and Pharmaceuticals Amgen Inc Novo Nordisk A/S
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Merck & Co Inc PRO: Playbooks JD/Com Inc
From CNBC.com News
Cramer's Lighting Round: 'I'm not going to recommend' Altria
Tags Business News Boeing Co Business
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Tags Biotech and Pharmaceuticals Health & Science Health care industry
From CNBC.com News
The 2 things that will drive the stock market after last week's Trump-Fed rally
Tags Breaking News: Markets ICL Group Ltd Investment strategy
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags AstraZeneca PLC Healthy Returns Social issues
From CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Tags Health & Science Biotechnology Health care industry
From CNBC.com News
Cerebras IPO has 'too much hair' as AI chipmaker tries to sell Wall Street on Nvidia alternative
Tags Business Barclays PLC Reddit Inc
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Tags Bristol/Myers Squibb Co Health care industry Eli Lilly and Co
From CNBC.com News
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
Tags Health & Science Biotech and Pharmaceuticals Health care industry
From CNBC.com News
AstraZeneca says staff detained in China amid reports of a drug-import investigation
Tags Business Pharmaceuticals AstraZeneca PLC
From CNBC.com News
India and Singapore agree to cooperate on chips as countries seek to strengthen partnership
Tags Semiconductors Technology International relations
From CNBC.com News
India's Modi expected to usher in new era of bilateral agreements in Singapore visit
Tags Breaking News: Technology Technology Asia Economy
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Health care industry Novartis AG Politics
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Biotech and Pharmaceuticals Johnson & Johnson Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Healthy Returns AstraZeneca PLC Merck & Co Inc
From CNBC.com News
Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030
Tickers CEO
Tags Markets Mad Money Investing
From CNBC.com News
Cramer's Lighting Round: 'You've got a winner' with Astra Zeneca
Tags Business News Business stocks
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Bristol/Myers Squibb Co Eli Lilly and Co Pharmaceuticals
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Health care industry Medicine Health & Science
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Business Companies Business News
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Business News Social issues Business
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Eli Lilly and Co Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
Tags GSK plc Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
Tags Merck & Co Inc Healthy Returns AstraZeneca PLC
From CNBC.com News
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today